References
Price DL, Sisodia SS (1998) Mutant genes in familial Alzheimer’s disease and transgenic models. Annu Rev Neurosci 21:479–505
Lambert JC, Ibrahim-Verbaas CA, Harold D et al (2013) Meta-analysis of 74,046 individuals identifies 11 new susceptibility loci for Alzheimer’s disease. Nat Genet 45:1452–1458
Dropcho EJ, Chen YT, Posner JB, Old LJ (1987) Cloning of a brain protein identified by autoantibodies from a patient with paraneoplastic cerebellar degeneration. Proc Nat Acad Sci 84:4552–4556
Salemi M, Barone C, Romano C, Ridolfo F et al (2013) KIF21A mRNA expression in patients with down syndrome. Neurol Sci 34:569–571
Lunnon K, Sattlecker M, Furney SJ et al (2013) A blood gene expression marker of early Alzheimer’s disease. J Alzheimers Dis 33:737–753
Chen YT, Rettig WJ, Yenamandra AK et al (1990) Cerebellar degeneration-related antigen: a highly conserved neuroectodermal marker mapped to chromosomes X in human and mouse USA. Proc Natl Acad Sci 87:3077–3081
Shaw CJ, Lupski JR (2004) Implications of human genome architecture for rearrangement-based disorders: the genomic basis of disease. Hum Mol Genet 1:R57–R64
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Bosco, P., Spada, R., Caniglia, S. et al. Cerebellar degeneration-related autoantigen 1 (CDR1) gene expression in Alzheimer’s disease. Neurol Sci 35, 1613–1614 (2014). https://doi.org/10.1007/s10072-014-1805-6
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10072-014-1805-6